Physician

Anar Askarovna Dossumbekova, M.D.

According to 2025 Medicare claims, Anar Dossumbekova, M.D. (NPI: 1467716803) practices allergy/immunology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN - MEDICAL GROUP (NPI: 1659488351; TIN: 232743545) and primary practice location at 19087-4557.

Dossumbekova's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 153 traditional Medicare patients, billed 688 HCPCS/CPT codes, and received $28,160 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,051 prescription claims across 124 beneficiaries totaling $713,626 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 32 claims. Open Payments data shows 5 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $162,442 to $28,160. In contrast, Part D prescription costs have moved sharply higher in recent years, from $12,493 to $713,626. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $9,620 to $531.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$128K$255K2018 Medicare payment: $162,442 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $255,270 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $132,828 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $185,475 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $142,895 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $22,581 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $28,160 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182036,480$162,442
20191829,569$255,270
20201345,202$132,828
20211276,888$185,475
20221055,002$142,895
202396417$22,581
2024153688$28,160

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$357K$714K2015 Drug cost: $12,493 (USD; Tot_Drug_Cst)2016 Drug cost: $19,318 (USD; Tot_Drug_Cst)2017 Drug cost: $20,646 (USD; Tot_Drug_Cst)2018 Drug cost: $128,228 (USD; Tot_Drug_Cst)2019 Drug cost: $242,618 (USD; Tot_Drug_Cst)2020 Drug cost: $310,385 (USD; Tot_Drug_Cst)2021 Drug cost: $304,207 (USD; Tot_Drug_Cst)2022 Drug cost: $366,019 (USD; Tot_Drug_Cst)2023 Drug cost: $680,159 (USD; Tot_Drug_Cst)2024 Drug cost: $713,626 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201521180$12,493
201639140$19,318
201740140$20,646
2018130503$128,228
2019149644$242,618
2020115538$310,385
2021113537$304,207
2022114566$366,019
2023109687$680,159
20241241,051$713,626

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$14K$28K2018 Medicare payment: $9,146 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,487 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $17,255 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $27,505 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $24,117 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $447 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $358 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R12$9,146
201911110$9,487
202037119$17,255
20212388$27,505
2022N/R105$24,117
2023N/R32$447
2024N/R32$358

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3636$134
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3848$110
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4747$88
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5976$70
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's5675$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab501,316$184,513
XolairOmalizumab381,064$154,174
Dupixent SyringeDupilumab32872$119,369
NucalaMepolizumab22616$82,282
TezspireTezepelumab-Ekko12354$51,077

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 daysNN/R11$285
E0570Nebulizer, with compressorYN/R21$74

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$111GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anar Askarovna Dossumbekova, M.D.?

Tedicare shows public-source Medicare data for Anar Askarovna Dossumbekova, M.D. (NPI 1467716803), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anar Askarovna Dossumbekova, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anar Askarovna Dossumbekova, M.D.?

Anar Askarovna Dossumbekova, M.D. is linked to UNIVERSITY OF PENN - MEDICAL GROUP (billing NPI 1659488351) in the available physician profile data.

Does Anar Askarovna Dossumbekova, M.D. have Open Payments data?

Anar Askarovna Dossumbekova, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.